Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | MTOR | P42345 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CETP | P11597 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | UBE2N | P61088 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5154050 | 0.92 | LMNA (0.57) | ALDH1A1LMNATDP1CYP3A4TSHR | |
| SCHEMBL5153473 | 0.92 | LMNA (0.57) | ALDH1A1LMNATDP1CYP3A4TSHR | |
| SCHEMBL30899588 | 0.91 | ALDH1A1 (0.58) | ALDH1A1LMNATDP1CYP3A4TSHR | |
| SCHEMBL4630852 | 0.89 | ALDH1A1 (0.50) | ALDH1A1LMNATDP1CYP3A4TSHR | |
| SCHEMBL30592702 | 0.86 | ALDH1A1 (0.55) | ALDH1A1LMNATDP1CYP3A4TSHR | |
| SCHEMBL8897874 | 0.86 | ALDH1A1 (0.59) | ALDH1A1LMNATDP1CYP3A4TSHR | |
| SCHEMBL8894270 | 0.84 | ALDH1A1 (0.57) | ALDH1A1LMNATDP1CYP3A4TSHR | |
| SCHEMBL2878053 | 0.83 | LMNA (0.61) | ALDH1A1LMNACYP3A4CYP2D6KDM4E | |
| SCHEMBL28338856 | 0.83 | LMNA (0.61) | ALDH1A1LMNACYP3A4CYP2D6KDM4E | |
| SCHEMBL182760 | 0.82 | ALDH1A1 (0.81) | ALDH1A1LMNATDP1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 768 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12415147-B2 | Foam control agent | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-09-16 | — | — | US | claimed |
| US-20240307416-A1 | FILM-FORMING COMPOSITIONS COMPRISING SALICYLIC ACID AND METHODS OF USE | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2024-09-19 | — | — | US | claimed |
| US-12090205-B2 | Poloxamer compositions with reduced sol-gel transition temperatures and methods of reducing the sol-gel transition temperature of poloxamer compositions | ROCHAL TECHNOLOGIES LLC (US) | 2024-09-17 | — | — | US | claimed |
| EP-1369037-B2 | Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria | SCHUELKE & MAYR GMBH (DE) | 2024-07-17 | — | — | EP | claimed |
| CN-118304193-A | External cream capable of preventing female climacteric symptoms | 珠海众赫生物技术有限公司 | 2024-07-09 | — | — | CN | claimed |
| EP-2916820-B1 | DELIVERY OF BIOLOGICALLY-ACTIVE AGENTS USING VOLATILE, HYDROPHOBIC SOLVENTS | ROCHAL TECH LLC (US) | 2023-10-11 | — | — | EP | claimed |
| CN-116421560-A | Microemulsion of albendazole ivermectin and preparation method thereof | 山东中牧兽药有限公司 | 2023-07-14 | — | — | CN | claimed |
| WO-2023007275-A1 | FILM-FORMING COMPOSITIONS COMPRISING SALICYLIC ACID AND METHODS OF USE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-02-02 | — | — | WO | claimed |
| US-11554086-B2 | Cosmetic composition comprising glycolic acid and methods of use | L'OREAL (FR) | 2023-01-17 | — | — | US | claimed |
| EP-3204037-B1 | COMPOSITIONS AND KITS FOR ENZYMATIC DEBRIDEMENT AND METHODS OF USING THE SAME | ROCHAL TECH LLC (US) | 2022-12-07 | — | — | EP | claimed |
| US-20040001797-A1 | Mixture of acid, anionic surfactant, calcium scavenger and antifoam agent; bactericides; viricides | PROCTER & GAMBLE COMPANY, THE | 2004-01-01 | — | — | US | claimed |
| US-20030235550-A1 | Antimicrobial compositions, products and methods employing same | PROCTER & GAMBLE COMPANY, THE | 2003-12-25 | — | — | US | claimed |
| US-20030232729-A1 | Glyceryl ethers as preservatives for cooling lubricants | AIR LIQUIDE, SANTE (INTERNATIONAL) (FR) | 2003-12-18 | — | — | US | claimed |
| EP-1369037-A1 | Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria | Air Liquide Santé (International) (FR) | 2003-12-10 | — | — | EP | claimed |
| EP-1369471-A1 | Glyceryl ethers as preservatives for cooling lubricants | Air Liquide Santé (International) (FR) | 2003-12-10 | — | — | EP | claimed |
| WO-2003055559-A1 | DIALKYL-SUBSTITUTED ACETIC ACID AND GLYCERIC ACID BASED ACTIVE SUBSTANCE COMBINATIONS AGAINST BACTERIA, MYCOTA AND VIRUSES | BEIERSDORF AG (DE) | 2003-07-10 | — | — | WO | claimed |
| EP-0747047-B1 | Combination of an antimicrobial compound (e.g. the lipoaminoacid N,n-octanoyl-glycine) and a monoalkylglycerol ether and its use as an antimicrobial agent | ROCHE POSAY LAB PHARMA (FR) | 1998-07-15 | — | — | EP | claimed |
| US-5736574-A | COMPRISING A HYDROLIPID AND AT LEAST ONE GLYCERYL MONOALKYL ETHER | LA ROCHE POSAY LABORATOIRE PHARMACEUTIQUE (FR) | 1998-04-07 | — | — | US | claimed |
| EP-0747047-A1 | Combination of an antimicrobial compound (e.g. the lipoaminoacid N,n-octanoyl-glycine) and a monoalkylglycerol ether and its use as an antimicrobial agent | LA ROCHE POSAY Laboratoire Pharmaceutique (FR) | 1996-12-11 | — | — | EP | claimed |
| EP-0547727-B1 | Skin and hands composition containing disinfectants and antiseptics | SCHUELKE & MAYR GMBH (DE) | 1996-03-13 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12415147-B2 | Foam control agent | MGLL, LIPA, LIPC | ALDH1A1 4024/4885LMNA 976/4885TDP1 1861/4885 |
| US-12090205-B2 | Poloxamer compositions with reduced sol-gel transition temperatures and methods of reducing the sol-gel transition temperature of poloxamer compositions | PAOX, HPGDS, SPTSSB | ALDH1A1 4457/4885LMNA 2898/4885TDP1 2971/4885 |
| US-11554086-B2 | Cosmetic composition comprising glycolic acid and methods of use | CUTA, UGCG, DGKI | ALDH1A1 2910/4885LMNA 1141/4885TDP1 2468/4885 |
| US-20240307416-A1 | FILM-FORMING COMPOSITIONS COMPRISING SALICYLIC ACID AND METHODS OF USE | SYVN1, CBLB, HTR2B | ALDH1A1 4098/4885LMNA 625/4885TDP1 746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.